Skip to content
Delayed ~15 min

BMY Bristol Myers Squibb

Permanent stock page ↗

Health Care · S&P 500

Next earnings: not announced yet

What 34 analyst firms say about Bristol Myers Squibb: their latest ratings, price targets and how far the stock is from them. How it works

62.14 USD−0.99 (−1.57%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+6.8%to the avg target 66.37 USD+4.23 USD
Buy 13 · Hold 18 · Sell 1

32 rated views · 35 analyst/firm records · 34 firms

Latest report30 Oct 2026avg report date 23 Aug
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • S&P 500 · Top Picks · 6MBelow the Radar threshold of 8024
  • S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8031

Recent analyst activity · last 90 days

Our tracked history has 26 reports on BMY from 20 analyst firms in the last 90 days (34 firms in the past year).

Comparing each firm's latest target with its previous one: 5 lowered it, 7 left it unchanged and 3 have their first observed target in the past year.

Ratings, latest available report against the previous one: 1 upgrade and 3 downgrades.

Latest observed target change: Morgan Stanley lowered its target from $41.00 (set 7 Oct 2026) to $40.00 on 30 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
ArgusJasper HellwegBuy5 Aug 202675.00 USD
Bank of America SecuritiesTim AndersonBuy30 Oct 202666.00 USD · 9 Oct 2026
BarclaysEmily FieldBuy29 Oct 202675.00 USD
BerenbergLuisa HectorHold4 Aug 202665.00 USD
BernsteinCourtney BreenHold13 Oct 202661.00 USD
BMO Capital MarketsEvan SeigermanHold18 Aug 202660.00 USD
Cantor FitzgeraldCarter GouldHold8 Oct 202653.00 USD
CitigroupGeoff MeachamHold3 Aug 202670.00 USD
DaiwaNarumi NakagiriHold11 May 202666.00 USD
DBSNico ChenBuy1 Jul 202660.00 USD
Deutsche BankUnnamed analystHold17 Dec 202565.00 USD
DZ BankElmar KrausBuy3 Aug 202673.00 USD
Erste GroupHans EngelHold25 Jun 2026—
Goldman SachsAsad HaiderBuy16 Oct 2026Conflicting reports · excluded
GuggenheimSeamus FernandezBuy31 Jul 202675.00 USD
HSBCRajesh KumarHold10 Sep 2026Conflicting reports · excluded
JefferiesAkash TewariBuy12 Oct 202676.00 USD
JPMorganChris SchottBuy31 Jul 202673.00 USD
Leerink PartnersDavid RisingerHold5 Oct 202659.00 USD
Morgan StanleyTerence FlynnSell30 Oct 202640.00 USD
Piper SandlerDavid AmsellemBuy26 Oct 202678.00 USD
Raymond JamesSean MccutcheonHold13 Aug 2026—
RBC Capital MarketsTrung HuynhHold19 Oct 202664.00 USD
RedburnSteven K ChesneyHold3 Aug 202653.00 USD
Roth CapitalUnnamed analystBuy5 Aug 202675.00 USD
ScotiabankLouise ChenHold9 Sep 202660.00 USD
TD CowenSteve M ScalaBuy5 Aug 202670.00 USD
TruistRobyn KarnauskasBuy31 Jul 202670.00 USD
TruistSrikripa Devarakonda—30 Oct 202670.00 USD
UBSMichael J YeeConflictConflicting reports · excluded5 Aug 202680.00 USD
Weiss RatingsUnnamed analyst—18 Aug 2026—
Wells FargoMohit BansalHold13 Oct 202660.00 USD
William BlairMatt PhippsHold12 Oct 2026—
Wolfe ResearchAlexandria HammondHold12 Apr 2026—
Data feed RESEARCHResearch TeamHold22 Oct 2026Conflicting reports · excluded

Partial coverage · checked 6 Nov (6 Nov 2026, 02:51 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.